Lecanemab in symptomatic PSEN1 p.Met233Val early-onset Alzheimer&#39;s disease: Neuroimaging safety, regional amyloid-PET dynamics, and longitudinal plasma biomarkers.

Leqembi (lecanemab-irmb) - Biogen, Eisai

PF-08653945 - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/42676462

Bugyeong Son; David M Holtzman; Hyunkee Kim; Min-Young Noh; Seung Hyun Kim; Wonjae Sung; Young-Eun Kim; Yun Young Choi

Sep 2, 2026